Heron Therap(HRTX.US)

Last Updated 19:00:00 ET
longbridge loading

Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility

Tip Ranks·
US
HRTX
-1.31%
US
XBI
-0.69%
US
IXJ
+0.79%
Tip Ranks·
US
HRTX
-1.31%
US
XBI
-0.69%
US
IXJ
+0.79%

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga_article·
US
HRTX
-1.31%
US
BMY
+1.74%
US
DRTS
+6.48%
benzinga_article·
US
HRTX
-1.31%
US
BMY
+1.74%
US
DRTS
+6.48%

Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.

benzinga_article·
US
HRTX
-1.31%
US
XBI
-0.69%
US
ARKG
+0.04%
benzinga_article·
US
HRTX
-1.31%
US
XBI
-0.69%
US
ARKG
+0.04%

Heron Therap | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 34.71 M

Earnings Watch·
US
HRTX
-1.31%
Earnings Watch·
US
HRTX
-1.31%

Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 | HRTX Stock News

StockTitan·
US
HRTX
-1.31%
StockTitan·
US
HRTX
-1.31%

Heron names Craig Collard amendment and revises retention agreements for Duarte, Forbes and Hensley

TradingView·
US
IBB
+0.10%
US
FBT
+0.54%
US
PBE
+0.11%
TradingView·
US
IBB
+0.10%
US
FBT
+0.54%
US
PBE
+0.11%
© 2026 Longbridge｜Disclaimer